Web11 mrt. 2024 · U.S. securities regulator says Hutchmed is one of five Chinese companies in danger of delisting, a week after company announced the retirement of its longtime CEO. Company’s shares have tumbled... WebHUTCHMED (Nasdaq/AIM:HCM;HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development … About Us - HUTCHMED Commercialization Over the past two decades, we have operated in China’s … Learn more about HUTCHMED's latest news and updates. We further plan to … News & Press Releases 12 Apr 2024 HUTCHMED Highlights Presentations at … Shareholder Information - HUTCHMED HUTCHMED aims to become a major pharmaceutical company developing … Research and Development - HUTCHMED Our prescription drugs business, conducted through our joint ventures (Shanghai …
Short Selling Turnover (Main Board) up to morning close (1)
Web2 mrt. 2024 · HUTCHMED China Limited focuses on targeted therapy and immunotherapy for cancer and immune diseases, as well as the manufacture and sales of related drugs. … Web12 apr. 2024 · Hong Kong, Shanghai & Florham Park, NJ — Wednesday, April 12, 2024: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today … christian jaros nhl
和黃醫藥 (0013.HK) 股價、新聞、報價和過往記錄 - Yahoo 財經
WebHUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development … WebHutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceutical company aiming to become a global leader in the discovery, development and commercialisation of targeted... Web25 mei 2015 · HUTCHISON WHAMPOA LIMITED (HKG:0013) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share HUTCHISON WHAMPOA LIMITED Hong Kong Stock ... CK HUTCHISON HOLDINGS LIMITED: 6.62%: 24 371: GROUPE BRUXELLES LAMBERT SA: 4.99%: 12 024: KOÇ HOLDING A.S.-7.35%: 10 215: … christian javier salary